Cargando…

Spatial lipidomics reveals brain region-specific changes of sulfatides in an experimental MPTP Parkinson’s disease primate model

Metabolism of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) to the neurotoxin MPP(+) in the brain causes permanent Parkinson’s disease-like symptoms by destroying dopaminergic neurons in the pars compacta of the substantia nigra in humans and non-human primates. However, the complete molecular...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaya, Ibrahim, Nilsson, Anna, Luptáková, Dominika, He, Yachao, Vallianatou, Theodosia, Bjärterot, Patrik, Svenningsson, Per, Bezard, Erwan, Andrén, Per E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372136/ https://www.ncbi.nlm.nih.gov/pubmed/37495571 http://dx.doi.org/10.1038/s41531-023-00558-1

Ejemplares similares

Neuropharmacokinetic visualization of regional and subregional unbound antipsychotic drug transport across the blood–brain barrier
por: Luptáková, Dominika, et al.
Publicado: (2021)

Basal ganglia neuropeptides show abnormal processing associated with L-DOPA-induced dyskinesia
por: Hulme, Heather, et al.
Publicado: (2022)

Molecular imaging identifies age-related attenuation of acetylcholine in retrosplenial cortex in response to acetylcholinesterase inhibition
por: Vallianatou, Theodosia, et al.
Publicado: (2019)

Mass spectrometry imaging identifies abnormally elevated brain l-DOPA levels and extrastriatal monoaminergic dysregulation in l-DOPA–induced dyskinesia
por: Fridjonsdottir, Elva, et al.
Publicado: (2021)

Cross-validated Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging Quantitation Protocol for a Pharmaceutical Drug and Its Drug-Target Effects in the Brain Using Time-of-Flight and Fourier Transform Ion Cyclotron Resonance Analyzers
por: Källback, Patrik, et al.
Publicado: (2020)

Integration of Mass Spectrometry Imaging and Machine Learning Visualizes Region-Specific Age-Induced and Drug-Target Metabolic Perturbations in the Brain
por: Vallianatou, Theodosia, et al.
Publicado: (2021)

Region-Specific and Age-Dependent Multitarget Effects of Acetylcholinesterase Inhibitor Tacrine on Comprehensive Neurotransmitter Systems
por: Fridjonsdottir, Elva, et al.
Publicado: (2021)

On-Tissue Chemical Derivatization for Comprehensive Mapping of Brain Carboxyl and Aldehyde Metabolites by MALDI–MS Imaging
por: Kaya, Ibrahim, et al.
Publicado: (2023)

Gastrointestinal and metabolic function in the MPTP-treated macaque model of Parkinson's disease
por: Delamarre, Anna, et al.
Publicado: (2020)

Prosaposin maintains lipid homeostasis in dopamine neurons and counteracts experimental parkinsonism in rodents
por: He, Yachao, et al.
Publicado: (2023)

Transplantation in the nonhuman primate MPTP model of Parkinson's disease: update and perspectives
por: Wianny, Florence, et al.
Publicado: (2017)

Impaired migratory phenotype of CD4(+) T cells in Parkinson’s disease
por: Mamula, Dejan, et al.
Publicado: (2022)

Decreased Rhes mRNA levels in the brain of patients with Parkinson’s disease and MPTP-treated macaques
por: Napolitano, Francesco, et al.
Publicado: (2017)

The repertoire of protein-sulfatide interactions reveal distinct modes of sulfatide recognition
por: Capelluto, Daniel G. S
Publicado: (2022)

Elevation of sulfatides in ovarian cancer: An integrated transcriptomic and lipidomic analysis including tissue-imaging mass spectrometry
por: Liu, Ying, et al.
Publicado: (2010)

Non-dopaminergic Alterations in Depression-Like FSL Rats in Experimental Parkinsonism and L-DOPA Responses
por: Schintu, Nicoletta, et al.
Publicado: (2020)

Polymorphonuclear Leukocyte Apoptosis Is Accelerated by Sulfatides or Sulfatides-Treated Salmonella Typhimurium Bacteria
por: Grishina, Zoryana V., et al.
Publicado: (2015)

Normalization and expression changes in predefined sets of proteins using 2D gel electrophoresis: A proteomic study of L-DOPA induced dyskinesia in an animal model of Parkinson's disease using DIGE
por: Kultima, Kim, et al.
Publicado: (2006)

Sulfatide Deficiency, an Early Alzheimer’s Lipidomic Signature, Causes Brain Ventricular Enlargement in the Absence of Classical Neuropathological Hallmarks
por: Palavicini, Juan Pablo, et al.
Publicado: (2022)

Local transgene expression and whole‐body transgenesis to model brain diseases in nonhuman primate
por: Chansel‐Debordeaux, Lucie, et al.
Publicado: (2019)

GRP78 Level Is Altered in the Brain, but Not in Plasma or Cerebrospinal Fluid in Parkinson’s Disease Patients
por: Baek, Jean-Ha, et al.
Publicado: (2019)

Dopamine Transporter Binding Is Unaffected by L-DOPA Administration in Normal and MPTP-Treated Monkeys
por: Fernagut, Pierre-Olivier, et al.
Publicado: (2010)

Endometrial stem cell transplantation in MPTP- exposed primates: an alternative cell source for treatment of Parkinson's disease
por: Wolff, Erin F, et al.
Publicado: (2015)

Magnetic resonance imaging and tensor-based morphometry in the MPTP non-human primate model of Parkinson’s disease
por: Modo, Michel, et al.
Publicado: (2017)

Age-dependent α-synuclein aggregation in the Microcebus murinus lemur primate
por: Canron, Marie-Hélène, et al.
Publicado: (2012)

The Association of Iron and the Pathologies of Parkinson’s Diseases in MPTP/MPP(+)-Induced Neuronal Degeneration in Non-human Primates and in Cell Culture
por: Shi, Liangqin, et al.
Publicado: (2019)

The levels of the NMDA receptor co-agonist D-serine are reduced in the substantia nigra of MPTP-lesioned macaques and in the cerebrospinal fluid of Parkinson’s disease patients
por: Nuzzo, Tommaso, et al.
Publicado: (2019)

The Antiparkinsonian and Antidyskinetic Mechanisms of Mucuna pruriens in the MPTP-Treated Nonhuman Primate
por: Lieu, Christopher A., et al.
Publicado: (2012)

Decreased Prosaposin and Progranulin in the Cingulate Cortex Are Associated with Schizophrenia Pathophysiology
por: He, Yachao, et al.
Publicado: (2022)

Immunological role of sulfatide in the pathogenesis of multiple sclerosis
por: Hamatani, Mio, et al.
Publicado: (2023)

Neighboring Pallidal Neurons Do Not Exhibit more Synchronous Oscillations than Remote Ones in the MPTP Primate Model of Parkinson's Disease
por: Mitelman, Rea, et al.
Publicado: (2011)

Potential Effects of Leukotriene Receptor Antagonist Montelukast in Treatment of Neuroinflammation in Parkinson’s Disease
por: Wallin, Johan, et al.
Publicado: (2021)

α-synuclein−lipoprotein interactions and elevated ApoE level in cerebrospinal fluid from Parkinson's disease patients
por: Paslawski, Wojciech, et al.
Publicado: (2019)

Antidepressant-like properties of sarizotan in experimental Parkinsonism
por: Zhang, Xiaoqun, et al.
Publicado: (2011)

Neuroimaging Analysis of the Dopamine Basis for Apathetic Behaviors in an MPTP-Lesioned Primate Model
por: Tian, LinLin, et al.
Publicado: (2015)

Reading Alterations in Parkinson's Disease Indicate Worse Cognitive Status
por: Tsitsi, Panagiota, et al.
Publicado: (2023)

Deficits in Motor Performance, Neurotransmitters and Synaptic Plasticity in Elderly and Experimental Parkinsonian Mice Lacking GPR37
por: Zhang, Xiaoqun, et al.
Publicado: (2020)

Oral ambroxol increases brain glucocerebrosidase activity in a nonhuman primate
por: Migdalska‐Richards, Anna, et al.
Publicado: (2017)

Prediction Models for Brain Distribution of Drugs Based on Biomimetic Chromatographic Data
por: Vallianatou, Theodosia, et al.
Publicado: (2022)

Sulfatides Partition Disabled-2 in Response to Platelet Activation
por: Drahos, Karen E., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_ug4k6ngrdc448p3bkvtjdb8fa1